A study conducted across 27 centers in India, known as the DiaFib-Liver Study, has revealed that liver disease should be considered the fourth major complication of diabetes. Analyzing over 9,000 patients with type 2 diabetes, researchers found that 26% had significant liver scarring, and 5% were at risk of cirrhosis. The study highlighted that fibrosis could occur even in individuals without fatty liver, indicating that standard checks may overlook many at risk. Experts are calling for the integration of liver fibrosis screening into routine diabetes care, akin to checks for eye and kidney health. Dr. Parag Rana, a contributor to the study, emphasized the need for early detection to prevent advanced liver damage. With over 100 million diabetics in India, the implications of this finding could affect millions. Preventive measures include lifestyle modifications such as maintaining a healthy weight, balanced diet, and regular monitoring of liver functions.